blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2061490

EP2061490 - MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.09.2018
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  06.10.2017
FormerGrant of patent is intended
Status updated on  29.06.2017
Most recent event   Tooltip05.06.2020Lapse of the patent in a contracting state
New state(s): HU, PT		published on 08.07.2020  [2020/28]
Applicant(s)For all designated states
Agency for Science, Technology and Research
1 Fusionopolis Way No 20-10 Connexis
Singapore 138632 / SG
[2009/22]
Inventor(s)01 / WANG, Yue
Institute of Molecular and Cell Biology
Proteos, 61 Biopolis Drive
Singapore 138673 / SG
02 / XU, Xiao-Li
Institute of Molecular and Cell Biology
Proteos, 61 Biopolis Drive
Singapore 138673 / SG
03 / LEE, Teck Ho, Raymond
Institute of Molecular and Cell Biology
Proteos, 61 Biopolis Drive
Singapore 138673 / SG
 [2017/45]
Former [2009/22]01 / WANG, Yue
Institute of Molecular and Cell Biology Proteos, 61 Biopolis Drive
Singapore 138673 / SG
02 / XU, Xiao-Li
Institute of Molecular and Cell Biology Proteos, 61 Biopolis Drive
Singapore 138673 / SG
03 / LEE, Teck Ho, Raymond
Institute of Molecular and Cell Biology Proteos, 61 Biopolis Drive
Singapore 138673 / SG
Representative(s)Jelsch, Emmanuel Edwin, et al
Katzarov S.A.
12, Avenue des Morgines
1213 Petit-Lancy / CH
[N/P]
Former [2017/45]Jelsch, Emmanuel Edwin, et al
Katzarov S.A.
Rue des Epinettes 19
1227 Geneva / CH
Former [2009/22]Jelsch, Emmanuel Edwin, et al
Katzarov S.A., Rue des Epinettes 19
1227 Geneva / CH
Application number, filing date07794275.321.08.2007
[2009/22]
WO2007SG00265
Priority number, dateUS20060823636P25.08.2006         Original published format: US 823636 P
[2009/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008024075
Date:28.02.2008
Language:EN
[2008/09]
Type: A1 Application with search report 
No.:EP2061490
Date:27.05.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 28.02.2008 takes the place of the publication of the European patent application.
[2009/22]
Type: B1 Patent specification 
No.:EP2061490
Date:08.11.2017
Language:EN
[2017/45]
Search report(s)International search report - published on:AU28.02.2008
(Supplementary) European search report - dispatched on:EP07.02.2011
ClassificationIPC:A61K38/00, A61K39/00, A61P31/10
[2009/22]
CPC:
C07K16/44 (EP,US); A61K39/395 (US); A61K38/14 (US);
A61P31/10 (EP); C07K16/14 (US); C12Q1/02 (US);
G01N33/566 (US); G01N2333/40 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/45]
Former [2009/22]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:MODULATOREN DER CANDIDA HYPHAL MORPHOGENESE UND IHRE VERWENDUNGEN[2009/22]
English:MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF[2009/22]
French:MODULATION DE LA MORPHOGENÈSE HYPHALE DE CANDIDA ET UTILISATIONS DE CELLE-CI[2009/22]
Entry into regional phase25.03.2009National basic fee paid 
25.03.2009Search fee paid 
25.03.2009Designation fee(s) paid 
25.03.2009Examination fee paid 
Examination procedure25.03.2009Examination requested  [2009/22]
08.08.2011Amendment by applicant (claims and/or description)
01.03.2012Despatch of a communication from the examining division (Time limit: M04)
03.07.2012Reply to a communication from the examining division
22.10.2012Despatch of a communication from the examining division (Time limit: M06)
22.02.2013Reply to a communication from the examining division
05.11.2013Despatch of a communication from the examining division (Time limit: M04)
06.03.2014Reply to a communication from the examining division
07.01.2015Despatch of a communication from the examining division (Time limit: M06)
03.07.2015Reply to a communication from the examining division
13.05.2016Despatch of a communication from the examining division (Time limit: M06)
14.09.2016Reply to a communication from the examining division
30.06.2017Communication of intention to grant the patent
25.09.2017Fee for grant paid
25.09.2017Fee for publishing/printing paid
25.09.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.03.2012
Opposition(s)09.08.2018No opposition filed within time limit [2018/42]
Fees paidRenewal fee
31.08.2009Renewal fee patent year 03
31.08.2010Renewal fee patent year 04
31.08.2011Renewal fee patent year 05
31.08.2012Renewal fee patent year 06
02.09.2013Renewal fee patent year 07
25.07.2014Renewal fee patent year 08
13.07.2015Renewal fee patent year 09
22.08.2016Renewal fee patent year 10
08.08.2017Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.08.2007
AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
MC08.11.2017
NL08.11.2017
PL08.11.2017
PT08.11.2017
RO08.11.2017
SE08.11.2017
SI08.11.2017
SK08.11.2017
TR08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
[2020/27]
Former [2020/16]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
MC08.11.2017
NL08.11.2017
PL08.11.2017
RO08.11.2017
SE08.11.2017
SI08.11.2017
SK08.11.2017
TR08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2019/15]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
MC08.11.2017
NL08.11.2017
PL08.11.2017
RO08.11.2017
SE08.11.2017
SI08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/52]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
PL08.11.2017
RO08.11.2017
SE08.11.2017
SI08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/41]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
PL08.11.2017
RO08.11.2017
SE08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/39]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
IT08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
PL08.11.2017
SE08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/37]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
PL08.11.2017
SE08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/35]AT08.11.2017
CY08.11.2017
CZ08.11.2017
DK08.11.2017
EE08.11.2017
ES08.11.2017
FI08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
SE08.11.2017
SK08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/24]AT08.11.2017
ES08.11.2017
FI08.11.2017
LT08.11.2017
LV08.11.2017
NL08.11.2017
SE08.11.2017
BG08.02.2018
GR09.02.2018
IS08.03.2018
Former [2018/23]AT08.11.2017
ES08.11.2017
FI08.11.2017
LT08.11.2017
NL08.11.2017
SE08.11.2017
GR09.02.2018
IS08.03.2018
Former [2018/22]ES08.11.2017
FI08.11.2017
LT08.11.2017
NL08.11.2017
Documents cited:Search[Y]EP0680974  (DAIICHI SEIYAKU CO [JP], et al) [Y] 1-15 *cf. abstract, page 2, lines 3-15, claims 1-12*;
 [A]WO2004091552  (SLESAREV VLADIMIR [US], et al) [A] 1-15*cf. abstract, page 1, lines 13-16, page 3, lines 12-22*;
 [Y]  - OGAWA T ET AL, "ENHANCEMENT OF SERUM ANTIBODY PRODUCTION IN MICE BY ORAL ADMINISTRATION OF LIPOPHILIC DERIVATIVES OF MURAMYLPEPTIDES AND BACTERIAL LIPOPOLYSACCHARIDES WITH BOVINE SERUM ALBUMIN", METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, PROUS, BARCELONA, ES, (19860101), vol. 8, no. 1, ISSN 0379-0355, pages 19 - 26, XP009142812 [Y] 1-15 *cf. summary*
 [A]  - SHIMI I R ET AL, "4,4'-isopropylidine-bis(2-isopropyl)phenol, a new inhibitor for cell wall formation of Bacillus subtilis", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (19760401), vol. 9, no. 4, ISSN 0066-4804, pages 580 - 584, XP009142808 [A] 1-15 *cf. abstract, and 1st para. of the left col. on page 580, furthermore the discussion part on page 583, last para. of the left col. bridging with col. on the right side*
International search[X]US4396607  (LEFRANCIER PIERRE [FR], et al);
 [X]US4522811  (EPPSTEIN DEBORAH A [US], et al)
by applicant   - J. BIOL. CHEM., vol. 276, pages 48988 - 48996
    - LIU, H., CURR. OPIN. MICROBIOL., (2001), vol. 4, pages 728 - 735
    - ROCHE, C.R. ET AL., MOL. BIOL. CELL, (2001), vol. 12, pages 3631 - 3643
    - CHAMAILLARD, M. ET AL., CELL MICROBIOL., (2003), vol. 5, pages 581 - 592
    - CHAMAILLARD, M., NAT. REV. IMMUNOL., (2003), vol. 4, pages 702 - 707
    - INOHARA, N.; NUNEZ, G., NAT. REV. IMMUNOL., (2003), vol. 3, pages 371 - 382
    - GIRARDIN, S.E.; PHILPOTT; D.J., EUR. J. IMMUNOL., (2004), vol. 34, pages 1777 - 1782
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.